Clinical Trials in Nashville

Showing 361-380 of 20,298 trials

Mechanisms of Weight Loss in Patients Diagnosed With Achalasia

NCT03063463

Currently there are no existing data to determine why some achalasia patients lose weight while others do not. The purpose of this study is to gather data from patients diagnosed with achalasia to determine if differences may be identified between those who lose weight and those who do not that would help us better understand the mechanism of weight loss in this population.

Achalasia

Vanderbilt University Medical Center7 participantsStarted Feb 2017

Nashville, Tennessee, United States

COMPLETEDPhase 3< 1 mile

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

NCT02231749

The purpose of this study is to compare the objective response rate, progression free survival and the overall survival of Nivolumab combined with Ipilimumab to Sunitinib monotherapy in patients with previously untreated Renal Cell Cancer.

Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma

Bristol-Myers Squibb1,096 participantsStarted Oct 2014

Duarte, California, United States • La Jolla, California, United States • Los Angeles, California, United States +186 more locations

Mechanisms of Weight Loss in Patients Diagnosed With Achalasia

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

Find Trials by Condition in Nashville

Botox or Botox With Esophageal Dilation in Patients With Achalasia

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

Transtibial Amputation Outcomes Study

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

A Study of LY3502970 in Participants With Type 2 Diabetes

NIBP Validation Study

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)